Home1466 • HKG
add
Baijin Life Science Holdings Ltd
Previous close
$0.71
Year range
$0.40 - $0.76
Market cap
548.40M HKD
Avg Volume
486.90K
P/E ratio
-
Dividend yield
-
Primary exchange
HKG
Market news
Financials
Income Statement
Revenue
Net income
| (HKD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | 35.45M | 182.23% |
Operating expense | 8.12M | 54.30% |
Net income | -3.11M | -168.64% |
Net profit margin | -8.78 | 4.88% |
Earnings per share | — | — |
EBITDA | 1.15M | 181.44% |
Effective tax rate | 369.26% | — |
Balance Sheet
Total assets
Total liabilities
| (HKD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 44.96M | 7.54% |
Total assets | 236.70M | 140.43% |
Total liabilities | 129.26M | 457.46% |
Total equity | 107.44M | — |
Shares outstanding | 679.25M | — |
Price to book | 5.46 | — |
Return on assets | 0.30% | — |
Return on capital | 0.41% | — |
Cash Flow
Net change in cash
| (HKD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -3.11M | -168.64% |
Cash from operations | -4.20M | -2,131.91% |
Cash from investing | 115.00K | -66.67% |
Cash from financing | 9.00M | 4,751.75% |
Net change in cash | 3.24M | 21,720.00% |
Free cash flow | 1.68M | 382.94% |
About
Founded
2014
Website
Employees
84
